患者预后-话题@MedSci - williamhill asia

#患者预后#

512篇内容 | 3836人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1692296, encodeId=f14216922967f, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=Clin Cancer Res：维奈托克治疗前依鲁替尼导入治疗可有效改善慢性淋巴细胞白血病患者预后, objectType=article, longId=737802, objectId=9316e3780270, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9316e3780270, replyNumber=0, likeNumber=74, createdTime=2022-10-24, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9316e3780270, moduleTitle=Clin Cancer Res：维奈托克治疗前依鲁替尼导入治疗可有效改善慢性淋巴细胞白血病患者预后, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=9316e3780270)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692295, encodeId=2c9a169229542, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=Heart：左室功能障碍的超声心动图特征与慢性肾脏病患者预后, objectType=article, longId=737825, objectId=6b51e3782570, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b51e3782570, replyNumber=0, likeNumber=81, createdTime=2023-02-26, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b51e3782570, moduleTitle=Heart：左室功能障碍的超声心动图特征与慢性肾脏病患者预后, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=6b51e3782570)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692293, encodeId=ed1816922939f, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=超高生存率与疾病控制率，质子重离子精准放疗有效提高骨肉瘤患者预后！, objectType=article, longId=733739, objectId=4d54e3373952, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d54e3373952, replyNumber=0, likeNumber=61, createdTime=2023-03-16, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d54e3373952, moduleTitle=超高生存率与疾病控制率，质子重离子精准放疗有效提高骨肉瘤患者预后！, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=4d54e3373952)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692288, encodeId=744d1692288fd, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=Lancet Oncol：尼拉帕利联合伊匹单抗维持治疗可改善晚期胰腺癌患者预后, objectType=article, longId=731946, objectId=c874e31946f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c874e31946f8, replyNumber=0, likeNumber=74, createdTime=2023-02-14, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c874e31946f8, moduleTitle=Lancet Oncol：尼拉帕利联合伊匹单抗维持治疗可改善晚期胰腺癌患者预后, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=c874e31946f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692279, encodeId=c6c016922e942, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=Lancet Oncol：新辅助化疗加用尼达尼布对晚期肌肉浸润性膀胱癌患者预后的影响, objectType=article, longId=724219, objectId=adc4e2421902, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adc4e2421902, replyNumber=0, likeNumber=78, createdTime=2022-06-12, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adc4e2421902, moduleTitle=Lancet Oncol：新辅助化疗加用尼达尼布对晚期肌肉浸润性膀胱癌患者预后的影响, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=adc4e2421902)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692285, encodeId=8644169228552, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=JAHA：高敏C反应蛋白与缺血性卒中或短暂性脑缺血发作患者预后之间的关系, objectType=article, longId=731047, objectId=43d4e3104797, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43d4e3104797, replyNumber=0, likeNumber=0, createdTime=2022-07-23, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43d4e3104797, moduleTitle=JAHA：高敏C反应蛋白与缺血性卒中或短暂性脑缺血发作患者预后之间的关系, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=43d4e3104797)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692286, encodeId=a6ac16922860f, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=Ther Adv Med Oncol：洛铂新辅助治疗可改善三阴性乳腺癌患者预后, objectType=article, longId=731076, objectId=fee6e3107677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fee6e3107677, replyNumber=0, likeNumber=72, createdTime=2022-08-15, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fee6e3107677, moduleTitle=Ther Adv Med Oncol：洛铂新辅助治疗可改善三阴性乳腺癌患者预后, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=fee6e3107677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692282, encodeId=030d169228208, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=Ther Adv Med Onco：骨转移对尿路上皮癌患者预后的预测意义, objectType=article, longId=726368, objectId=ed4be2636815, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed4be2636815, replyNumber=0, likeNumber=77, createdTime=2022-05-24, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed4be2636815, moduleTitle=Ther Adv Med Onco：骨转移对尿路上皮癌患者预后的预测意义, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=ed4be2636815)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692281, encodeId=fcc71692281ef, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=DCR：II期结肠癌壁外淋巴、血管和神经周围浸润对于患者预后的影响, objectType=article, longId=724832, objectId=2a0be2483243, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a0be2483243, replyNumber=0, likeNumber=74, createdTime=2022-04-28, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a0be2483243, moduleTitle=DCR：II期结肠癌壁外淋巴、血管和神经周围浸润对于患者预后的影响, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=2a0be2483243)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692273, encodeId=f6ea16922e329, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=JAHA：慢性血管扩张剂对血管痉挛性心绞痛患者预后的影响, objectType=article, longId=301983, objectId=02ba30198306, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02ba30198306, replyNumber=0, likeNumber=84, createdTime=2022-10-18, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02ba30198306, moduleTitle=JAHA：慢性血管扩张剂对血管痉挛性心绞痛患者预后的影响, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=02ba30198306)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692297, encodeId=c94c169229e3a, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病患者中性粒细胞/淋巴细胞比率高预示经皮冠状动脉介入治疗患者预后不良, objectType=article, longId=739206, objectId=df2ee39206bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2ee39206bd, replyNumber=0, likeNumber=84, createdTime=2022-11-29, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2ee39206bd, moduleTitle=Cardiovasc Diabetol：2型糖尿病患者中性粒细胞/淋巴细胞比率高预示经皮冠状动脉介入治疗患者预后不良, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=df2ee39206bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692289, encodeId=4c1c169228919, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=European Radiology：他来了！可预测基底动脉闭塞性卒中患者预后的新的影像学评分, objectType=article, longId=734180, objectId=b9bbe3418001, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9bbe3418001, replyNumber=0, likeNumber=70, createdTime=2023-06-28, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9bbe3418001, moduleTitle=European Radiology：他来了！可预测基底动脉闭塞性卒中患者预后的新的影像学评分, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=b9bbe3418001)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692287, encodeId=d827169228ec0, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=院内发生卒中的患者预后差！北京协和医院研究, objectType=article, longId=731432, objectId=f1b0e3143286, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1b0e3143286, replyNumber=0, likeNumber=63, createdTime=2023-05-12, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1b0e3143286, moduleTitle=院内发生卒中的患者预后差！北京协和医院研究, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=f1b0e3143286)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692278, encodeId=a2c816922e855, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=NEJM：纳武单抗+化疗作为可切除肺癌的新辅助治疗可大大改善患者预后, objectType=article, longId=724211, objectId=c373e242115e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c373e242115e, replyNumber=0, likeNumber=89, createdTime=2022-04-21, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c373e242115e, moduleTitle=NEJM：纳武单抗+化疗作为可切除肺癌的新辅助治疗可大大改善患者预后, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=c373e242115e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692267, encodeId=c75d169226ebd, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=DCR: 直肠癌中淋巴细胞与单核细胞和血小板与淋巴细胞比率可以对患者预后进行预测, objectType=article, longId=299070, objectId=583d2990e018, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=583d2990e018, replyNumber=0, likeNumber=62, createdTime=2022-05-07, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=583d2990e018, moduleTitle=DCR: 直肠癌中淋巴细胞与单核细胞和血小板与淋巴细胞比率可以对患者预后进行预测, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=583d2990e018)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692274, encodeId=a74516922e4a2, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=Cardiovasc Diabetol：应激性高血糖比率对急性ST段抬高型心肌梗死患者预后的预测意义, objectType=article, longId=302237, objectId=db1430223ed2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db1430223ed2, replyNumber=0, likeNumber=80, createdTime=2022-09-01, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db1430223ed2, moduleTitle=Cardiovasc Diabetol：应激性高血糖比率对急性ST段抬高型心肌梗死患者预后的预测意义, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=db1430223ed2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692256, encodeId=8e891692256ec, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=Ther Adv Med Oncol：中肿石明教授团队回顾性研究发现仑伐替尼+特瑞普利单抗+肝动脉灌注化疗（HAIC）可改善晚期肝细胞癌患者预后, objectType=article, longId=293055, objectId=28ee293055ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28ee293055ec, replyNumber=0, likeNumber=75, createdTime=2022-02-05, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28ee293055ec, moduleTitle=Ther Adv Med Oncol：中肿石明教授团队回顾性研究发现仑伐替尼+特瑞普利单抗+肝动脉灌注化疗（HAIC）可改善晚期肝细胞癌患者预后, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=28ee293055ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692266, encodeId=78fc169226634, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=Blood：经典霍奇金淋巴瘤儿童患者预后的预测模型！, objectType=article, longId=295492, objectId=dbc729549217, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbc729549217, replyNumber=0, likeNumber=63, createdTime=2022-04-28, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbc729549217, moduleTitle=Blood：经典霍奇金淋巴瘤儿童患者预后的预测模型！, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=dbc729549217)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692265, encodeId=a00e169226584, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=Front Oncol：围手术期化疗与胃肝样腺癌(HAS)患者预后的关系, objectType=article, longId=295129, objectId=43332951291a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43332951291a, replyNumber=0, likeNumber=70, createdTime=2022-04-19, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43332951291a, moduleTitle=Front Oncol：围手术期化疗与胃肝样腺癌(HAS)患者预后的关系, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=43332951291a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1692264, encodeId=1b2c1692264e4, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, objectTitle=BMC Cancer：阴性淋巴结(NLN)数量对III期结肠癌患者预后影响, objectType=article, longId=295099, objectId=e645295099ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e645295099ce, replyNumber=0, likeNumber=78, createdTime=2022-04-13, rootId=0, userName=bnurmamat, userId=8f4729287700, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e645295099ce, moduleTitle=BMC Cancer：阴性淋巴结(NLN)数量对III期结肠癌患者预后影响, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=e645295099ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] williamhill asia 话题小助手

患者预后

2020-05-29

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

Clin Cancer Res：维奈托克治疗前依鲁替尼导入治疗可有效改善慢性淋巴细胞白血病患者预后

2022-10-24

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

Heart：左室功能障碍的超声心动图特征与慢性肾脏病患者预后

2023-02-26

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

超高生存率与疾病控制率，质子重离子精准放疗有效提高骨肉瘤患者预后！

2023-03-16

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

Lancet Oncol：尼拉帕利联合伊匹单抗维持治疗可改善晚期胰腺癌患者预后

2023-02-14

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

Lancet Oncol：新辅助化疗加用尼达尼布对晚期肌肉浸润性膀胱癌患者预后的影响

2022-06-12

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

JAHA：高敏C反应蛋白与缺血性卒中或短暂性脑缺血发作患者预后之间的关系

2022-07-23

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

Ther Adv Med Oncol：洛铂新辅助治疗可改善三阴性乳腺癌患者预后

2022-08-15

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

Ther Adv Med Onco：骨转移对尿路上皮癌患者预后的预测意义

2022-05-24

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

DCR：II期结肠癌壁外淋巴、血管和神经周围浸润对于患者预后的影响

2022-04-28

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

JAHA：慢性血管扩张剂对血管痉挛性心绞痛患者预后的影响

2022-10-18

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

Cardiovasc Diabetol：2型糖尿病患者中性粒细胞/淋巴细胞比率高预示经皮冠状动脉介入治疗患者预后不良

2022-11-29

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

European Radiology：他来了！可预测基底动脉闭塞性卒中患者预后的新的影像学评分

2023-06-28

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

院内发生卒中的患者预后差！北京协和医院研究

2023-05-12

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

NEJM：纳武单抗+化疗作为可切除肺癌的新辅助治疗可大大改善患者预后

2022-04-21

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

DCR: 直肠癌中淋巴细胞与单核细胞和血小板与淋巴细胞比率可以对患者预后进行预测

2022-05-07

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

Cardiovasc Diabetol：应激性高血糖比率对急性ST段抬高型心肌梗死患者预后的预测意义

2022-09-01

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

Ther Adv Med Oncol：中肿石明教授团队回顾性研究发现仑伐替尼+特瑞普利单抗+肝动脉灌注化疗（HAIC）可改善晚期肝细胞癌患者预后

2022-02-05

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

Blood：经典霍奇金淋巴瘤儿童患者预后的预测模型！

2022-04-28

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

Front Oncol：围手术期化疗与胃肝样腺癌(HAS)患者预后的关系

2022-04-19

bnurmamat (审核中...)

前往app查看评论内容

#患者预后#

BMC Cancer：阴性淋巴结(NLN)数量对III期结肠癌患者预后影响

2022-04-13

科室
- - 订阅+
  - 更多科室
工具
服务